Skip to content

A STUDY TO FIND OUT IF PREMEDICATION WITH MIDAZOLAM BEFORE MASK VENTILATION FACILITATES EASE OF VENTILATION BY FACE MASK IN PATIENTS WITH SUSPECTED DIFFICULT BAG AND MASK VENTILATION:A RANDOMISED CONTROL TRIAL

A STUDY TO EVALUATE THE EFFECT OF MIDAZOLAM PREMEDICATION ON MASK VENTILATION IN PATIENTS WITH ANTICIPATED DIFFICULT BAG AND MASK VENTILATION:A RANDOMISED CONTROL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051068
Enrollment
92
Registered
2023-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: midazolam: group A patients will be treated with IV midazolam PREMEDICATION @ 0.035mg/kg and anxiety and sedation levels along with responsiveness score of Modified Obsevers Assessment

Sponsors

Dr Mrigakhi Bordoloi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 patients undergoing elective surgery under GA 2 asa 1 and 2 3 patients in whom difficult mask ventilation anticipated a. edentulous b.bearded c.BMI more than equal to 26 to less than equal to 35 d.history of snoring

Exclusion criteria

Exclusion criteria: 1.Patients with previous anaesthetic record of difficult intubation 2.Previous history of cervical spine disease or cervical spine surgery 3.History of chronic usage of opiods,benzodiazepines,antipsychotics 4.Pregnancy 5.Presence of muscular weakness or Neuromuscular disorders 6.Diagnosed case of Obstructive sleep apnea 7.Patients allergic to midazolam 8.Patients planned for awake intubation 9.Patients with increased risk of aspiration of gastric contents.

Design outcomes

Primary

MeasureTime frame
Midazolam premedication facilitates ease on ventilation by facemask following induction of anaesthesia in patients with anticipated difficult bag and mask ventilationTimepoint: outcome will be assessed at baseline

Secondary

MeasureTime frame
To compare sedation scores between 2 groups. To compare any other relevant findingsTimepoint: Anxiety and sedation levels measured before and 3 minutes after treatment of midazolam premedication using numerical rating scale and responsiveness scores of modified observers assessment of alertness/sedation scale

Countries

India

Contacts

Public ContactMRIGAKHI BORDOLOI

GAUHATI MEDICAL COLLEGE AND HOSPITAL

11980pran@gmail.com7002181200

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026